We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

Why the FDA’s full approval of the Pfizer-BioNTech vaccine could be a turning point

2 0 0

The Food and Drug Administration on Monday granted full approval of the Pfizer-BioNTech coronavirus vaccine for those 16 years old and above. This long-anticipated regulatory change marks a crucial turning point in the effort to increase vaccine uptake.

There are five reasons. First, though many employers, universities and government entities have already implemented vaccine mandates, others have been waiting for this official stamp of approval. United Airlines, the Pentagon and universities from Louisiana to Minnesota have all said they will institute vaccine requirements after full approval. A school district in Culver City, Calif., has already mandated inoculation of eligible students. I expect more schools to follow given the full approval, adding the coronavirus vaccine to the long list of childhood vaccinations that are already required for students to enroll.

Sign up for The Checkup With Dr. Wen, a newsletter on how to navigate the pandemic and other public health challenges

Second, some who have not yet been vaccinated cite lack of full FDA approval as a major reason for their hesitancy. Even though more than 200 million Pfizer doses have been safely administered in the United States and hundreds of millions more worldwide, anti-vaccine activists have adopted a narrative that the vaccine was........

© Washington Post

Get it on Google Play